Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs in Progressive MS and NMO
NCT01364246Phase 2Unknown
- Sponsor
- Beike Biotechnology
- Start
- Jan 2010
- Primary completion
- Mar 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in multiple sclerosis (MS), neuromyelitis optica (NMO), sponsored by Beike Biotechnology. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)neuromyelitis optica (NMO)
Beyond the preview
Go deeper on NCT01364246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364246.